What do the Cialis label and trials say about tadalafil while on a cycle?
| Use | Labelled dose and schedule |
|---|---|
| As needed, ED | Starting dose 10 mg in most patients before anticipated sexual activity, which may be increased to 20 mg or decreased to 5 mg; maximum frequency once per day in most patients; shown to improve erectile function compared to placebo up to 36 hours after dosing1 |
| Once daily, ED | Starting dose 2.5 mg at about the same time every day, without regard to timing of sexual activity; may be increased to 5 mg based on individual efficacy and tolerability1 |
| Once daily, BPH | 5 mg at about the same time every day1 |
| Once daily, ED and BPH | 5 mg1 |
For erectile dysfunction, the Cialis label gives a once-daily starting dose of 2.5 mg that may be increased to 5 mg, or an as-needed starting dose of 10 mg in most patients;1 searches of DailyMed, ClinicalTrials.gov and PubMed found no label guidance and no human trial of tadalafil in people on a steroid cycle.
Strengths and labelled schedules
The table is set at the top of the page
The Cialis label gives these doses for ED, BPH or both; searches found no label guidance for people on a steroid cycle.1 The Cialis label describes tablets for oral use;1 searches showed no powder or syringe form, so no mixing step or syringe mark is sourced. Cialis is supplied as 5, 10 and 20 mg tablets in bottles of 30, and the label says not to split them.1 The label says the tablets may be taken without regard to food.1
Is there a tablet to mix, or a 40 mg dose?
The one tadalafil liquid the DailyMed search found is Tadliq, a ready-made oral suspension of 20 mg per 5 mL labelled for pulmonary arterial hypertension, whose label gives 40 mg as 10 mL once daily.2 The Adcirca label, for pulmonary arterial hypertension, gives 40 mg (two 20 mg tablets) taken once daily.3 The Cialis label has no 40 mg dose.31
What trials used
The trials below tested tadalafil in men with ED, men with BPH, men after nerve-sparing prostatectomy and patients with pulmonary arterial hypertension; none was in people on a steroid cycle.4567
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Brock 2002, ED (pooled five trials) | 2.5, 5, 10 or 20 mg as needed, up to once daily, against placebo4 | 1,112 men | 12 weeks |
| Roehrborn 2008, BPH | Once daily at 2.5, 5, 10 or 20 mg, against placebo5 | 1,058 men | 12 weeks, after a 4-week placebo run-in |
| Moncada 2015, after nerve-sparing prostatectomy | 5 mg once daily, 20 mg on demand, or placebo6 | 423 men aged 68 or under (139, 143 and 141 per arm) | 9 months double-blind, a 6-week washout, then 3 months open-label 5 mg once daily |
| Galiè 2009 (PHIRST), pulmonary arterial hypertension | 2.5, 10, 20 or 40 mg orally once daily, against placebo7 | 405 patients, treatment-naive or on bosentan | 16 weeks |
Label adjustments for kidneys, liver and interacting drugs
For creatinine clearance of 30 to 50 mL/min the label gives an as-needed starting dose of 5 mg not more than once per day and a maximum of 10 mg not more than once in every 48 hours.1 Below 30 mL/min or on hemodialysis, the label gives an as-needed maximum of 5 mg not more than once in every 72 hours and does not recommend once-daily use.1 With potent CYP3A4 inhibitors such as ketoconazole or ritonavir, the label limits the as-needed dose to 10 mg, not to exceed once every 72 hours, and gives a maximum of 2.5 mg on its every-day schedule.1 The label says concomitant use of nitrates in any form is contraindicated.1 For mild or moderate hepatic impairment (Child Pugh Class A or B) the label caps the as-needed dose at 10 mg once per day, with no data above 10 mg; it does not recommend use in severe impairment (Child Pugh Class C).1
Tadalafil on a cycle: what is sourced
Searches of DailyMed, ClinicalTrials.gov and PubMed found no label guidance and no human trial of tadalafil in people on anabolic steroid or testosterone cycles. The nearest trial is Buvat 2011 (TADTEST), in 173 men aged 45 to 80 with total testosterone of 4 ng/mL or less (or bioavailable testosterone of 1 ng/mL or less) who had not responded to PDE5 inhibitors: they took tadalafil 10 mg once a day for 4 weeks and, if that was not successful, were randomized to placebo or a 1% testosterone gel (50 mg/5 g), to be increased to 10 mg testosterone if results were clinically unsatisfactory; this is not a steroid cycle.8 The CASTRO survey (Ip 2019), of 40 anabolic steroid users and 179 non-users at four San Francisco gyms, found steroid users more likely to misuse prescription drugs including tadalafil and sildenafil; it gives no dose.9 Related guides: TRT, hCG for men, anastrozole on TRT, Aromasin for men and post-cycle and ancillaries.
Storage
The Cialis label gives 25°C for the tablets, with excursions permitted to 15-30°C.1
Frequently asked questions
Is tadalafil on the WADA list?
A search of the WADA 2026 Prohibited List for the word tadalafil found no passage holding it; that is the absence of a word, not a WADA statement on tadalafil.10
References
- Eli Lilly and Company (FDA label). These highlights do not include all the information needed to use CIALIS safely and effectively. See full prescribing information for CIALIS. CIALIS (tadalafil) tablets, for oral use Initial U.S. Approval: 2003. 2026. dailymed.nlm.nih.gov
- CMP Pharma (FDA label). These highlights do not include all the information needed to use TADLIQ safely and effectively. See full prescribing information for TADLIQ. TADLIQ ® (tadalafil) oral suspension Initial U.S. Approval: 2003. 2022. dailymed.nlm.nih.gov
- FDA label (Adcirca). These highlights do not include all the information needed to use ADCIRCA safely and effectively. See full prescribing information for ADCIRCA. ADCIRCA (tadalafil) tablets for oral administration Initial U.S. Approval: 2003. 2025. dailymed.nlm.nih.gov
- PubMed. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. 2002. pubmed.ncbi.nlm.nih.gov
- PubMed. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. 2008. pubmed.ncbi.nlm.nih.gov
- PMC. Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy. 2014. pmc.ncbi.nlm.nih.gov
- PubMed. Tadalafil therapy for pulmonary arterial hypertension. 2009. pubmed.ncbi.nlm.nih.gov
- PubMed. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study). 2011. pubmed.ncbi.nlm.nih.gov
- PubMed. Anabolic steroid users' misuse of non-traditional prescription drugs. 2019. pubmed.ncbi.nlm.nih.gov
- WADA. WORLD ANTI-DOPING CODE. wada-ama.org